Ovarian Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer
Research To Practice | Oncology Videos · Dr. Neil Love
June 4, 20241h 32m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Ms Courtney Arn, Dr Floor J Backes, Dr Kathleen N Moore and Ms Jaclyn Shaver, including the following topics:
- Introduction: The Incidence, Pathogenesis and Prognosis of Ovarian Cancer (0:00)
- Genetic Testing for Newly Diagnosed Advanced Ovarian Cancer (11:01)
- The Role of PARP Inhibitor Maintenance for Newly Diagnosed Advanced Ovarian Cancer (19:02)
- Side Effects Associated with PARP Inhibitors (29:58)
- Dosing, Adherence and Other Issues with PARP Inhibitors for Ovarian Cancer (48:29)
- The Potential Role of PARP Inhibitors in Combination with Anti-PD-1/PD-L1 Antibodies for Advanced Ovarian Cancer Management (54:11)
- PARP Inhibitors for Relapsed/Refractory Ovarian Cancer (1:00:36)
- The Current Role of Mirvetuximab Soravtansine for Ovarian Cancer Treatment (1:07:14)
- Toxicities with Mirvetuximab Soravtansine (1:11:53)
- The Incidence and Management of HER2-Positive Ovarian Cancer (1:18:18)